↓ Skip to main content

Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation

Overview of attention for article published in BMC Cancer, May 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
89 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cancer-derived exosomes from HER2-positive cancer cells carry trastuzumab-emtansine into cancer cells leading to growth inhibition and caspase activation
Published in
BMC Cancer, May 2018
DOI 10.1186/s12885-018-4418-2
Pubmed ID
Authors

Mark Barok, Maija Puhka, Gyorgy Vereb, Janos Szollosi, Jorma Isola, Heikki Joensuu

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 17 19%
Researcher 13 15%
Student > Master 10 11%
Student > Bachelor 9 10%
Student > Postgraduate 5 6%
Other 12 13%
Unknown 23 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 22 25%
Agricultural and Biological Sciences 11 12%
Pharmacology, Toxicology and Pharmaceutical Science 9 10%
Medicine and Dentistry 7 8%
Chemistry 5 6%
Other 7 8%
Unknown 28 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2018.
All research outputs
#23,391,126
of 26,017,215 outputs
Outputs from BMC Cancer
#7,281
of 9,124 outputs
Outputs of similar age
#302,757
of 342,263 outputs
Outputs of similar age from BMC Cancer
#175
of 214 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 9,124 research outputs from this source. They receive a mean Attention Score of 4.8. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,263 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.